2-n-Nonyl-1,3-dioxolane
| Code | Size | Price |
|---|
| TAR-T29359-100mg | 100mg | £417.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
2-n-Nonyl-1,3-dioxolane is a biochemical. It is used as an absorption and penetration enhanceron transdermal.
CAS:
4353-06-4
Formula:
C12H24O2
Molecular Weight:
200.322
Purity:
0.98
SMILES:
CCCCCCCCCC1OCCO1
References
1. Sha M, Yin LF, Xu W, Chen YZ. [Effects of 2-n-nonyl-1,3-dioxolane as an enhanceron transdermal absorption of Salvia miltiorrhiza gel]. Zhongguo Zhong Yao Za Zhi. 2007 Mar;32(6):487-9. Chinese. PubMed PMID: 17552151.
2. El Maghraby GM, Campbell M, Finnin BC. Mechanisms of action of novel skin penetration enhancers: phospholipid versus skin lipid liposomes. Int J Pharm. 2005 Nov 23;305(1-2):90-104. Epub 2005 Sep 30. PubMed PMID: 16199131.
3. Fuhrman J, Shafer L, Repertinger S, Chan T, Hansen LA. Mechanisms of SEPA 0009-induced tumorigenesis in v-rasHa transgenic Tg.AC mice. Toxicol Pathol. 2005;33(6):623-30. PubMed PMID: 16176921.
4. Usta MF, Sanabria J, Bivalacqua TJ, Hellstrom WJ. Feline penile erection induced by topical glans penis application of combination alprostadil and SEPA (Topiglan). Int J Impot Res. 2004 Feb;16(1):73-7. Erratum in: Int J Impot Res. 2004 Jun;16(3):303.. Sanabriav, J corrected to Sanabria, J. PubMed PMID: 14963475.